<DOC>
	<DOCNO>NCT00252200</DOCNO>
	<brief_summary>Use BNP ( nesiritide ) v placebo help protect kidney function patient undergoing heart bypass surgery .</brief_summary>
	<brief_title>BNP ( Nesiritide ) v . Placebo Protect Kidney Function Patients Undergoing Heart Bypass Surgery .</brief_title>
	<detailed_description>This randomize , double-blind , placebo control study low dose nesiritide prevent renal insufficiency cardiopulmonary bypass surgery . Patients include great mild renal insufficiency preoperatively define creatinine clearance le 50 mL/minute determine Cockroft-Gault formula . The infusion nesiritide ( BNP ) 0.005 mcg/Kg/minute placebo begin 1 hour surgery run 24 hour start induction anesthesia prior cardiopulmonary bypass .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Patients &gt; 18 year old , undergoing cardiac surgery require cardiopulmonary bypass baseline creatinine clearance &lt; 50 ml/min dialysis dependent . Exclusion criterion : Cardiogenic shock hypotension systolic BP &lt; 90 mmHg . Patients acute chronic aortic dissection . Patients enrolled study effect renal function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>